# Venus Medtech and Healium form joint venture for RDN products

Venus Medtech (Qiming Medical) announced a joint venture with Israeli company Healium to form Renaly, which will develop, manufacture and commercialize Healium's next-generation renal denervation (RDN) devices globally. Venus Medtech will be the controlling shareholder.

- Type: Partnership
- Announced: 2021-06-30
- Status: announced
- Products: renal denervation (RDN) devices
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Venus Medtech](https://endata.com/companies/34506.md) (partner)
- [Healium](https://endata.com/companies/56127.md) (partner)
- [Renaly](https://endata.com/companies/56128.md) (partner)

## Sources

- [beta.zhitongcaijing.com](http://beta.zhitongcaijing.com/content/detail/504903.html), 2021-06-30: "启明医疗-B(02500)发布公告，已与以色列高科技公司Healium成立合资公司Renaly，以引进Healium的新一代去肾交感神经术(RDN)创新器械。"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.